Triazol compounds for treating biofilm formation

Details for Australian Patent Application No. 2008252964 (hide)

Owner Novartis AG

Inventors Reid, David

Agent Davies Collison Cave

Pub. Number AU-B-2008252964

PCT Pub. Number WO2008/142094

Priority 07108650.8 22.05.07 EP

Filing date 21 May 2008

Wipo publication date 27 November 2008

Acceptance publication date 1 December 2011

International Classifications

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

3 December 2009 PCT application entered the National Phase

  PCT publication WO2008/142094 Priority application(s): WO2008/142094

1 December 2011 Application Accepted

  Published as AU-B-2008252964

12 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008252973-Method for protecting wood stacks from infestation by wood pests

2008252943-Benzamides useful as S1P receptor modulators